Royal DSM completed the acquisition of Glycom for 826m.

Royal DSM, a global science-based company in nutrition, health and sustainable living, completed the acquisition of Glycom, a supplier of human milk oligosaccharides, for $826m. "Our companies have a great fit together, with a shared passion for purpose-led and science-based solutions in Nutrition & Health. This acquisition is an attractive and logical next step for DSM enabling us to provide our customers with innovative Early Life Nutrition solutions in our Human Nutrition business," Geraldine Matchett and Dimitri de Vreeze Royal DSM Co-CEOs.